WO2026013633 - METHODS OF PURIFYING AN ENVELOPED VIRUS
National phase entry is expected:
Publication Number
WO/2026/013633
Publication Date
15.01.2026
International Application No.
PCT/IB2025/057037
International Filing Date
11.07.2025
Title **
[English]
METHODS OF PURIFYING AN ENVELOPED VIRUS
[French]
PROCÉDÉS DE PURIFICATION D'UN VIRUS ENVELOPPÉ
Applicants **
CSL BEHRING LLC
Inventors
BRANDT, Tobias
LAUX, Holger
VOGEL, Jessica Elisabeth
Priority Data
63/670,242
12.07.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3282 | |
| EPO | Filing, Examination, Granting | 28454 | |
| Japan | Filing, Examination, Granting | 3120 | |
| South Korea | Filing, Examination, Granting | 4154 | |
| USA | Filing, Examination, Granting | 10110 |
Total:
49,120
Contact Us
Abstract[English]
The present disclosure relates generally to the manufacturing of gene therapy products, and specifically to methods of purifying an enveloped virus from a cell culture fluid, comprising a filtration medium.[French]
La présente invention concerne de manière générale la fabrication de produits de thérapie génique, et spécifiquement des procédés de purification d'un virus enveloppé à partir d'un liquide de culture cellulaire, comprenant un milieu de filtration.